Predicting BRCA1 and BRCA2 gene mutation carriers: Comparison of LAMBDA, BRCAPRO, Myriad II, and modified Couch models

Familial Cancer

Volumn 6, Issue 4, 2007, Pages 473-482

  Lindor, Noralane M ^a   Lindor, Rachel A ^b   Apicella, Carmel ^c   Dowty, James G ^c   Ashley, Amanda ^a   Hunt, Katherine ^d   Mincey, Betty A ^e   Wilson, Marcia ^a   Smith, M Cathie ^e   Hopper, John L ^c  

^a Mayo Clinic   (United States)

^b St Johns University School of Nursing   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MAYO CLINIC   (United States)

^e MAYO CLINIC   (United States)

Author keywords

Ashkenazi Jewish; Bayesian; BRCA1; BRCA2; Breast cancer; Risk prediction

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BAYES THEOREM; COMPUTER PROGRAM; CONTROLLED STUDY; GENE MUTATION; HETEROZYGOTE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; ONCOGENE; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; ROC CURVE; THEORETICAL MODEL;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; COMPUTER SIMULATION; FEMALE; HETEROZYGOTE; HUMANS; JEWS; MIDDLE AGED; MODELS, GENETIC; MUTATION; SOFTWARE;

EID: 35448980374     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-007-9150-z     Document Type: Article

References (30)

1. Antoniou A, Pharoah P, Narod S et al (2003) Average risk of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117-1130
2. King M, Marks J, Mandell J et al (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643-646
3. Heimdal K, Maehle L, Apold J et al (2003) The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer. Eur J Cancer 39(15):2205-2213
4. Consortium TBCL (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91(15):1310-1316
5. Thompson D, Easton D (2002) Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94:1358-1365
6. Medeiros F, Muto M, Lee Y et al (2006) The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 30(2):230-236
7. Narod S, Offit K (2005) Prevention and management of hereditary breast cancer. J Clin Oncol 23(8):1656-1663
8. Sogaard M, Kjaer S, Gayther S (2006) Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention. Acta Obstet Gynecol Scand 85(1):93-105
9. ASCO ASoCO (1996) Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996. J Clin Oncol 14:1730-1736
10. Apicella C, Andrews L, Hodgson S et al (2003) Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a defined personal and family history in an Ashkenazi Jewish woman (LAMBDA). Breast Cancer Res 5(6):R206-R216
11. Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20(6):1480-90
12. Parmigiani G, Berry D, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62(1):145-158
13. Berry D, Iversen EJ, Gudbjartsson D et al (2002) BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20(11):2701-2712
14. Couch F, DeShano M, Blackwood M et al (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336(20):1409-1415
15. National Cancer Institute (2003) Surveillance, Epidemiology, and End Results SEER program stat database: incidence, SEER 9 Regs public-use. Version 5.2 (computer program). National Cancer Institute, Bethesda, MD
16. DeLong E, DeLong D, Clarke-Pearson D (1988) Comparing the areas under two to more correlated receiver operating curves: a nonparametric approach. Biometrics 44:837-845
17. Cox D, Snell E (1989) Analysis of binary data, 2nd edn. Chapman & Hall, London
18. R Development Core Team (2005) R: a language and environment for statistical computing. R Foundation for Stastistical Computing, Vienna, Austria. http://www.R-project.org. Cited 27 Sept 2006
19. Antoniou A, Easton D (2006) Risk prediction models for familial breast cancer. Future Oncol 2:257-274
20. James P, Doherty R, Harris M et al (2006) Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. J Clin Oncol 24(4):707-715
21. Antoniou A, Durocher F, Smith P et al (2005) BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families. Breast Cancer Res 8(1):R3
22. Barcenas C, Hosain G, Arun B et al (2006) Assessing BRCA carrier probabilities in extended families. J Clin Oncol 24(3):354-360
23. Nanda R, Schumm L, Cummings S et al (2005) Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294(15):1925-1933
24. Euhus D, Smith K, Robinson L et al (2002) Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst 94(11):844-851
25. Gilpin C, Carson N, Hunter A (2000) A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center. Clin Genet 58(4):299-308
26. Evans D, Eccles D, Rahman N et al (2004) A new scoring system for the chances of identifying a BRCA1 AND BRCA2mutation outperforms existing models including BRCAPRO. J Med Genet 41(6):474-480
27. Antoniou A, Pharoah P, Smith P et al (2004) The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer 91(8):1580-1590
28. Gerdes A-M, Cruger D, Thomassen M et al (2006) Evaluation of two different models to predict BRCA1 and BRCA2 mutations in a cohort of Danish hereditary breast and/or ovarian cancer families. Clin Genet 69:171-179
29. Kang H, Williams R, Leary J et al (2006) Evaluation of models to predict BRCA germline mutations. Br J Cancer 95:914-920
30. Simard J, Dumont M, Moisan A et al (2007) Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer. J Med Genet 44(2):107-121